Technical Analysis for ATRS - Antares Pharma, Inc.

Grade Last Price % Change Price Change
grade D 2.75 -2.14% -0.06
ATRS closed down 2.14 percent on Monday, May 20, 2019, on 58 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ATRS trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -2.14%
Shooting Star Candlestick Bearish -2.14%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.14%
Doji - Bearish? Reversal -2.14%
Outside Day Range Expansion -2.14%
Fell Below 20 DMA Bearish -3.51%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.51%
NR7 Range Contraction -3.51%

Older signals for ATRS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Biotechnology Health Pharmaceutical Pharmacology Psoriasis Rheumatoid Arthritis Medical Equipment Overactive Bladder Testosterone Deficiency Teva Pharmaceutical Industries
Is ATRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.96
52 Week Low 2.4
Average Volume 1,024,934
200-Day Moving Average 3.2039
50-Day Moving Average 3.0016
20-Day Moving Average 2.8605
10-Day Moving Average 2.868
Average True Range 0.1333
ADX 18.02
+DI 18.3152
-DI 23.2475
Chandelier Exit (Long, 3 ATRs ) 2.7101
Chandelier Exit (Short, 3 ATRs ) 2.9999
Upper Bollinger Band 3.0688
Lower Bollinger Band 2.6522
Percent B (%b) 0.23
BandWidth 14.563887
MACD Line -0.04
MACD Signal Line -0.037
MACD Histogram -0.0029
Fundamentals Value
Market Cap 430.12 Million
Num Shares 156 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -22.92
Price-to-Sales 5.48
Price-to-Book 7.21
PEG Ratio -0.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.91
Resistance 3 (R3) 2.91 2.86 2.88
Resistance 2 (R2) 2.86 2.82 2.86 2.87
Resistance 1 (R1) 2.80 2.79 2.78 2.80 2.86
Pivot Point 2.75 2.75 2.74 2.75 2.75
Support 1 (S1) 2.70 2.71 2.67 2.70 2.64
Support 2 (S2) 2.65 2.69 2.65 2.63
Support 3 (S3) 2.59 2.65 2.62
Support 4 (S4) 2.59